Literature DB >> 23249909

Estimates of illnesses, hospitalizations and deaths caused by major bacterial enteric pathogens in young children in the United States.

Elaine Scallan1, Barbara E Mahon, Robert M Hoekstra, Patricia M Griffin.   

Abstract

BACKGROUND: Many enteric pathogens disproportionately affect young children. However, higher incidences of laboratory-confirmed illness may be explained, at least in part, by higher rates of medical care-seeking and stool sample submission in this age group. We estimated the overall number of bacterial enteric illnesses among children <5 years old in the United States caused by Campylobacter, Escherichia coli O157, nontyphoidal Salmonella, Shigella and Yersinia enterocolitica.
MATERIALS AND METHODS: We used a statistical model that scaled counts of laboratory-confirmed illnesses from the Foodborne Diseases Active Surveillance Network up to an estimated number of illnesses in the United States, adjusting for the surveillance steps needed for an illness to be laboratory diagnosed (medical care sought, stool sample submitted, bacterial culture performed, laboratory tested for pathogen, laboratory test sensitivity).
RESULTS: We estimated that 5 bacterial enteric pathogens caused 291,162 illnesses each year among children <5 years old, resulting in 102,746 physician visits, 7830 hospitalizations and 64 deaths. Nontyphoidal Salmonella caused most illnesses (42%), followed by Campylobacter (28%), Shigella (21%), Y. enterocolitica (5%) and E. coli O157 (3%). The estimated annual number of physician visits ranged from 3763 for E. coli O157 to 44,369 for nontyphoidal Salmonella. Nontyphoidal Salmonella was estimated to cause most hospitalizations (4670) and deaths (38).
CONCLUSIONS: Bacterial enteric infections cause many illnesses in US children. Compared with the general population, enteric illnesses among children <5 years old are more likely to be diagnosed. However, overall rates of illness remain higher in children after adjusting for underdiagnosis in both groups.

Entities:  

Mesh:

Year:  2013        PMID: 23249909     DOI: 10.1097/INF.0b013e31827ca763

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  35 in total

1.  Synergistic Killing of Pathogenic Escherichia coli Using Camel Lactoferrin from Different Saudi Camel Clans and Various Antibiotics.

Authors:  Hussein A Almehdar; Nawal Abd El-Baky; Abdulqader A Alhaider; Saud A Almuhaideb; Abdullah A Alhaider; Raed S Albiheyri; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Protein J       Date:  2019-08       Impact factor: 2.371

Review 2.  Economics and financing of vaccines for diarrheal diseases.

Authors:  Sarah M Bartsch; Bruce Y Lee
Journal:  Hum Vaccin Immunother       Date:  2014-04-22       Impact factor: 3.452

3.  Bacterial Enteric Infections Among Older Adults in the United States: Foodborne Diseases Active Surveillance Network, 1996-2012.

Authors:  Elaine Scallan; Stacy M Crim; Arthur Runkle; Olga L Henao; Barbara E Mahon; Robert M Hoekstra; Patricia M Griffin
Journal:  Foodborne Pathog Dis       Date:  2015-06       Impact factor: 3.171

4.  Online reports of foodborne illness capture foods implicated in official foodborne outbreak reports.

Authors:  Elaine O Nsoesie; Sheryl A Kluberg; John S Brownstein
Journal:  Prev Med       Date:  2014-08-11       Impact factor: 4.018

5.  Salmonella FraE, an Asparaginase Homolog, Contributes to Fructose-Asparagine but Not Asparagine Utilization.

Authors:  Anice Sabag-Daigle; Anindita Sengupta; Henry M Blunk; Pradip K Biswas; Mary Claire Cron; Alexander J Bogard; Edward J Behrman; Venkat Gopalan; Brian M M Ahmer
Journal:  J Bacteriol       Date:  2017-10-17       Impact factor: 3.490

Review 6.  Shiga toxins expressed by human pathogenic bacteria induce immune responses in host cells.

Authors:  Moo-Seung Lee; Myung Hee Kim; Vernon L Tesh
Journal:  J Microbiol       Date:  2013-12-19       Impact factor: 3.422

7.  Identification of Bacterial Species That Can Utilize Fructose-Asparagine.

Authors:  Anice Sabag-Daigle; Jikang Wu; Mikayla A Borton; Anindita Sengupta; Venkat Gopalan; Kelly C Wrighton; Vicki H Wysocki; Brian M M Ahmer
Journal:  Appl Environ Microbiol       Date:  2018-02-14       Impact factor: 4.792

8.  Characteristics of Campylobacter and Salmonella Infections and Acute Gastroenteritis in Older Adults in Australia, Canada, and the United States.

Authors:  Alice E White; Nadia Ciampa; Yingxi Chen; Martyn Kirk; Andrea Nesbitt; Beau B Bruce; Elaine Scallan Walter
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

9.  Salmonella-Mediated Inflammation Eliminates Competitors for Fructose-Asparagine in the Gut.

Authors:  Jikang Wu; Anice Sabag-Daigle; Mikayla A Borton; Linnea F M Kop; Blake E Szkoda; Brooke L Deatherage Kaiser; Stephen R Lindemann; Ryan S Renslow; Siwei Wei; Carrie D Nicora; Karl K Weitz; Young-Mo Kim; Joshua N Adkins; Thomas O Metz; Prosper Boyaka; Venkat Gopalan; Kelly C Wrighton; Vicki H Wysocki; Brian M M Ahmer
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

10.  Changes in the Occurrence of Gastrointestinal Infections after COVID-19 in Korea.

Authors:  So Yun Ahn; Ji Young Park; In Seok Lim; Soo Ahn Chae; Sin Weon Yun; Na Mi Lee; Su Yeong Kim; Byung Sun Choi; Dae Yong Yi
Journal:  J Korean Med Sci       Date:  2021-06-21       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.